Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Azurity Pharmaceuticals, Inc with status Current. The shortage was first posted on Apr 10, 2020.
Shortage details
- Status
- Current
- Company
- Azurity Pharmaceuticals, Inc
- Package NDC
- 52536-125-10
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)
- Initial Posting
- Apr 10, 2020